ARCHIVES

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

NCI Cooperative Group, Cancer Center Trials Listed

January 25, 2008

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Improved Prediction Of Cancer To Increase Pressure On Prevention, Greenwald Says

August 15, 1986